ATRS
Envestnet Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,231
| Closed | -$79K | – | 4134 |
|
|
2022
Q1 | $79K | Sell |
19,231
-2,579
| -12% | -$10.6K | ﹤0.01% | 3829 |
|
|
2021
Q4 | $78K | Buy |
21,810
+5,682
| +35% | +$20.3K | ﹤0.01% | 3781 |
|
|
2021
Q3 | $59K | Buy |
16,128
+3,761
| +30% | +$13.8K | ﹤0.01% | 3626 |
|
|
2021
Q2 | $54K | Buy |
+12,367
| New | +$54K | ﹤0.01% | 3599 |
|
|
2020
Q2 | – | Sell |
-58,136
| Closed | -$137K | – | 3207 |
|
|
2020
Q1 | $137K | Sell |
58,136
-4,031
| -6% | -$9.5K | ﹤0.01% | 2802 |
|
|
2019
Q4 | $292K | Buy |
62,167
+9,689
| +18% | +$45.5K | ﹤0.01% | 2746 |
|
|
2019
Q3 | $176K | Buy |
52,478
+4,780
| +10% | +$16K | ﹤0.01% | 2889 |
|
|
2019
Q2 | $157K | Buy |
47,698
+1,765
| +4% | +$5.81K | ﹤0.01% | 2918 |
|
|
2019
Q1 | $139K | Buy |
+45,933
| New | +$139K | ﹤0.01% | 2872 |
|